JournalsHub
.online
Find My Journal
MN

Michael A. Nauck

Universitätsmedizin Greifswald DE

ORCID iD 0000-0002-5749-6954
587
Publications
66,210
Citations
110
H-Index
313
i10-Index
7.03
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

585 total

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial

Juan P. Frías, Michael A. Nauck, Joanna Van, Mark E Kutner, Xuewei Cui et al. - The Lancet, 2018
Cited by 780 OpenAlex

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes PDF

Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, Ele Ferrannini et al. - Diabetologia, 2015
Cited by 688 OpenAlex

Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects

Carolyn F. Deacon, Michael A. Nauck, M. Toft-Nielsen, Lone Pridal, B. Willms et al. - Diabetes, 1995
Cited by 716 OpenAlex

Research Topics

Diabetes Treatment and Management (446) Diabetes Management and Research (176) Metabolism, Diabetes, and Cancer (174) Pancreatic function and diabetes (134) Pharmacology and Obesity Treatment (66)

Affiliations

University of North Carolina at Chapel Hill
US 2017 - 2014
University of Copenhagen
DK 2004 - 1995
American Cancer Society
US 2015 - 2015
Steno Diabetes Centers
DK 1996 - 1996
University of Freiburg
DE 2001 - 1979

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now